CollabRx Teams with MedPage Today to Introduce Digital Tool for Patient-Specific Genomic Approaches to Cancer Treatment
07:01 EDT 8 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Tegal Corporation (NASDAQ: TGAL) today announced that its recently
acquired CollabRx, Inc., subsidiary signed an exclusive license
agreement to provide a version of its proprietary Therapy Finder™ tool
to MedPage
Today,...
Other Sources for this Article
Tegal Corporation / CollabRx, Inc.
James M. Karis, Co-CEO
(650)
352-4790
jkaris@collabrx.com
or
Robert
Ferri Partners, LLC, Investor Relations for Tegal/CollabRx
Robert
Ferri
(415) 575-1589 (direct)
robert.ferri@robertferri.com
or
Everyday
Health, Inc.
Jennifer Perciballi, Vice President, Public Relations
(646)
728-9777 office
(646) 476-1245 mobile
jperciballi@everydayhealthinc.com
More From BioPortfolio on "CollabRx Teams with MedPage Today to Introduce Digital Tool for Patient-Specific Genomic Approaches to Cancer Treatment"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
